Jan 25, 2024
COHEN VETERANS BIOSCIENCE AND 22 JUMPS ANNOUNCE PARACHUTING WITH PURPOSE: RECOGNIZING THE CRISIS OF VETERANS SUICIDE AS A RESULT OF TRAUMATIC BRAIN INJURY (TBI) AND PTSD
Nov 02, 2020
New Research Partnership Pushes for Increased Transparency & Publication of Negative Research
Oct 19, 2020
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders
Sep 14, 2020
Global Preclinical Data Forum and European College of Neuropsychopharmacology Announce the Winner of the 2020 Best Negative Data Prize
May 07, 2020
New Collaboration Gives Veterans Better Access To Innovative Research Trials
Jan 29, 2020
Traumatic Brain Injuries in Soldiers Need Immediate Attention & New Solutions
Nov 11, 2019
Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics
Oct 08, 2019
Landmark Study Identifies Six Genetic Markers of Post-Traumatic Stress Disorder (PTSD) Risk
Jun 27, 2019
Cohen Veterans Bioscience Issues National PTSD Awareness Day Progress Report
Apr 08, 2019
Study Identifies Post-Traumatic Stress Disorder (PTSD) Brain Imaging Biomarker
Oct 11, 2018
The Michael J. Fox Foundation Partners with Cohen Veterans Bioscience on BRAIN Commons, Harnessing the Power of Big Data for Brain Diseases
Sep 06, 2018
Cohen Veterans Bioscience Expands Digital Health Platform with Early Signal Expertise
Feb 21, 2018
Wounded Warrior Project: Blood Tests to Treat PTSD
Sep 28, 2017
Cohen Veterans Bioscience Partners to Build Wellness Platform for Brain Disorders
Sep 27, 2017
OCC Collaborates with Cohen Veterans Bioscience on Brain Commons
Sep 27, 2017
Wounded Warrior Project Partners with Cohen Veterans Bioscience to Treat PTSD